Výsledky vyhledávání - Kazuhiro Nouso
- Zobrazuji výsledky 1 - 20 z 43
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
Detection of <i>K‐ras</i> gene mutation by liquid biopsy in patients with pancreatic cancer Autor Hideaki Kinugasa, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Chihiro Dohi, Koichiro Tsutsumi, Hironari Kato, Takehiro Matsubara, Hiroyuki Okada, Kazuhide Yamamoto
Vydáno 2015Artigo -
6
-
7
Role of hepatic resection in patients with intermediate‐stage hepatocellular carcinoma: A multicenter study from Japan Autor Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Kunihiko Tsuji, Atsushi Hiraoka, Ei Itobayashi, Kazuhiro Nouso, Kazuya Kariyama, Toru Ishikawa, Masashi Hirooka, Yoichi Hiasa
Vydáno 2017Artigo -
8
Measurement of Spleen Stiffness by Acoustic Radiation Force Impulse Imaging Identifies Cirrhotic Patients With Esophageal Varices Autor Yoshitaka Takuma, Kazuhiro Nouso, Youichi Morimoto, Junko Tomokuni, Akiko Sahara, Nobuyuki Toshikuni, Hiroyuki Takabatake, Hiroyuki Shimomura, Akira Doi, Ichiro Sakakibara, Kazuhiro Matsueda, Hiroshi Yamamoto
Vydáno 2012Artigo -
9
Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry Autor Yusuke Yamamoto, Toshihiro Sakurai, Zhen Chen, Takayuki Furukawa, Siddabasave Gowda B. Gowda, Yue Wu, Kazuhiro Nouso, Yuki Fujii, Yuki Yoshikawa, Hitoshi Chiba, Shu‐Ping Hui
Vydáno 2020Artigo -
10
L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway Autor Hisashi Ishikawa, Akinobu Takaki, Ryuichiro Tsuzaki, Tetsuya Yasunaka, Kazuko Koike, Yasuyuki Shimomura, Hiroyuki Seki, Hiroshi Matsushita, Yasuhiro Miyake, Fusao Ikeda, Hidenori Shiraha, Kazuhiro Nouso, Kazuhide Yamamoto
Vydáno 2014Artigo -
11
Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies Autor Kazuya Kariyama, Kazuhiro Nouso, Akiko Wakuta, Ayano Oonishi, Hidenori Toyoda, Toshifumi Tada, Atsushi Hiraoka, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Koichi Takaguchi, Akemi Tsutsui, Noritomo Shimada, Takashi Kumada
Vydáno 2019Artigo -
12
Twist expression promotes migration and invasion in hepatocellular carcinoma Autor Noriyuki Matsuo, Hidenori Shiraha, Tatsuya Fujikawa, Nobuyuki Takaoka, Naoki Ueda, Shigetomi Tanaka, Shinichi Nishina, Yutaka Nakanishi, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Takahito Yagi, Kazuhide Yamamoto
Vydáno 2009Artigo -
13
Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue Autor Soichiro Ako, Kazuhiro Nouso, Hideaki Kinugasa, Chihiro Dohi, Hiroshi Matushita, Sho Mizukawa, Shinichiro Muro, Yutaka Akimoto, Daisuke Uchida, Takeshi Tomoda, Kazuyuki Matsumoto, Shigeru Horiguchi, Koichiro Tsutsumi, Hironari Kato, Hiroyuki Okada
Vydáno 2016Artigo -
14
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan Autor Kazuhiro Nouso, Koji Miyahara, Daisuke Uchida, Kenji Kuwaki, Namiki Izumi, Masao Omata, Takafumi Ichida, Masatoshi Kudo, Yonson Ku, Norihiro Kokudo, Michiie Sakamoto, O Nakashima, Tadatoshi Takayama, Osamu Matsui, Yutaka Matsuyama, Kazuhiro Yamamoto
Vydáno 2013Artigo -
15
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis Autor Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Akiko Wakuta, Ayano Oonishi, Teiji Kuzuya, Hidenori Toyoda, Toshifumi Tada, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Koichi Takaguchi, Akemi Tsutsui, Noritomo Shimada, Masatoshi Kudo, Takashi Kumada
Vydáno 2020Artigo -
16
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD Autor Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Satoshi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse
Vydáno 2023Artigo -
17
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pu... Autor Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Masashi Hirooka, Kunihiko Tsuji, Ei Itobayashi, Kazuya Kariyama, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Kouji Joko, Hideki Kawasaki, Yoichi Hiasa, Kojiro Michitaka
Vydáno 2017Artigo -
18
Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis Autor Koji Miyahara, Kazuhiro Nouso, Shunsuke Saito, Sakiko Hiraoka, Keita Harada, Sakuma Takahashi, Yuki Morimoto, Sayo Kobayashi, Fusao Ikeda, Yasuhiro Miyake, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada, Maho Amano, Kazuko Hirose, Shin‐Ichiro Nishimura, Kazuhide Yamamoto
Vydáno 2013Artigo -
19
Runt‐related transcription factor 3 reverses epithelial–mesenchymal transition in hepatocellular carcinoma Autor Shigetomi Tanaka, Hidenori Shiraha, Yutaka Nakanishi, Shinichi Nishina, Minoru Matsubara, Shigeru Horiguchi, Nobuyuki Takaoka, Masaya Iwamuro, Junro Kataoka, Kenji Kuwaki, Hiroaki Hagihara, Junichi Toshimori, Hideki Ohnishi, Akinobu Takaki, Shinichiro Nakamura, Kazuhiro Nouso, Takahito Yagi, Kazuhide Yamamoto
Vydáno 2012Artigo -
20
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis Autor Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, Koichi Takaguchi, Ei Itobayashi, Kazuya Kariyama, Hironori Ochi, Kazuto Tajiri, Masashi Hirooka, Noritomo Shimada, Toru Ishikawa, Yoshihiko Tachi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Kouji Joko, Yoichi Hiasa, Kojiro Michitaka, Masatoshi Kudo
Vydáno 2018Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Hepatocellular carcinoma
Gastroenterology
Oncology
Cancer
Chemotherapy
Lenvatinib
Sorafenib
Atezolizumab
Bevacizumab
Biology
Immunotherapy
Confidence interval
Hazard ratio
Disease
Nivolumab
Pathology
Gene
Genetics
Surgery
Biochemistry
Fatty liver
Liver function
Proportional hazards model
Steatohepatitis
Adverse effect
Cancer research
Carcinoma
Cirrhosis